ID: 199376 Improved Pain Outcomes and Therapy Longevity After Salvage Using Novel SCS Systems: European Experience

Some patients implanted with a Spinal Cord Stimulation (SCS) device for treatment of chronic pain can experience loss or attenuation in therapeutic efficacy over time. To avoid or cope with this potential issue, customized delivery of neurostimulation may be an important tool in that various SCS-device waveforms and programming options can be applied more precisely in order to optimize treatment to the needs of the individual patient. However, technologies that offer patient-specific customization capabilities are not accessible to long-term implanted patients using older devices. Thus, in order to access these new technologies, patients can undergo a "conversion" to a different SCS system that does possess these capabilities. In this study, we assessed a cohort of previously-implanted patients who converted to a new SCS device capable of combination therapy (simultaneous or sequential delivery of multiple available waveforms), enhanced algorithmic-based stimulation field targeting, and waveform automation.